Literature DB >> 2888651

Adenosine-provoked angina pectoris-like pain--time characteristics, influence of autonomic blockade and naloxone.

C Sylvén1, B Jonzon, R Brandt, B Beermann.   

Abstract

In a study to characterize the time characteristics and the influence of blockade of beta, cholinergic and opioid receptors on the chest pain induced by adenosine, this agent was given as a bolus into a peripheral vein of six healthy volunteers (4 men) 24-45 years of age. On the first day the maximum tolerable dose was determined in each case. On the second day three doses of adenosine (1/3, 2/3, and a full maximum tolerable dose) and three doses of placebo were given as single blind doses in randomized order. Thereafter metoprolol (10 mg to males, 8 mg to females), followed by 1 mg atropine and then 0.4 mg naloxone were given intravenously. After each agent the test procedure was repeated. Heart rate and atrio-ventricular blocks were recorded by electrocardiography and respiration by dynamic spirometry. One minute after each dose of adenosine, the chest pain was scored. The maximum tolerable dose of adenosine was 8.0-15.9 mg. All subjects experienced angina pectoris-like pain. Following injection, onset of respiratory stimulation, AV-block and chest pain occurred after 14 +/- 4.0, 19 +/- 5.4 and 21 +/- 6.4 s, the differences being highly significant. Maximal respiratory stimulation occurred after 18 +/- 4.6, not statistically different from the onset of AV-block which in its turn occurred earlier (P less than 0.005) than the time for maximal central chest pain, 29 +/- 7.8 seconds. Metoprolol induced a 20% slowing of heart rate. After atropine there was a 30% faster heart rate.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888651     DOI: 10.1093/eurheartj/8.7.738

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  5 in total

1.  Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X).

Authors:  P M Elliott; K Krzyzowska-Dickinson; R Calvino; C Hann; J C Kaski
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

2.  Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias.

Authors:  A C Rankin; K G Oldroyd; E Chong; A P Rae; S M Cobbe
Journal:  Br Heart J       Date:  1989-09

3.  Plasma adenosine concentrations during adenosine-induced respiratory stimulation in man.

Authors:  P G Reid; A H Watt; W J Penny; A C Newby; A P Smith; P A Routledge
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  The therapeutic and diagnostic cardiac electrophysiological uses of adenosine.

Authors:  A D Malcolm; C J Garratt; A J Camm
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

Review 5.  Mechanisms of pain in angina pectoris--a critical review of the adenosine hypothesis.

Authors:  C Sylvén
Journal:  Cardiovasc Drugs Ther       Date:  1993-11       Impact factor: 3.727

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.